Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

InnoCan Pharma Corporation Proxy Solicitation & Information Statement 2025

May 7, 2025

47788_rns_2025-05-07_578b18a0-0f1b-42ad-b50f-c496a287a4f5.pdf

Proxy Solicitation & Information Statement

Open in viewer

Opens in your device viewer

May 7, 2025

ODYSSEY

Filed via SEDAR+

To All Applicable Exchanges and Securities Administrators

Subject: Innocan Pharma Corporation (the "Issuer") Notice of Meeting and Record Date

Dear Sir/Madam:

We are pleased to confirm the following information with respect to the Issuer's upcoming meeting of securityholders:

Meeting Type: Annual Special Meeting
Meeting Date: June 26, 2025
Record Date for Notice of Meeting: May 22, 2025
Record Date for Voting (if applicable): May 22, 2025
Beneficial Ownership Determination Date: May 22, 2025
Class of Securities Entitled to Vote: Common Shares
ISIN: CA45783P1027
Issuer sending proxy materials directly to NOBOs: No
Issuer paying for delivery to OBOs: Yes
Notice and Access for Beneficial Holders: No
Notice and Access for Registered Holders: No

In accordance with applicable securities regulations we are filing this information with you in our capacity as agent of the Issuer.

Yours truly,

Odyssey Trust Company

as agent for Innocan Pharma Corporation